James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 2,544,794 shares at $3.38 ($6.1M) on 2024-12-19, disclosed to the SEC on 2024-12-20.
Open-market sale of $6.1M CKPT by CEO, President and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.87 | 602,167 | $2.3M | 37.9% |
| 2 | $3.87 | 602,167 | $2.3M | 37.9% |
| 3 | $3.38 | 220,230 | $744K | 12.1% |
| 4 | $3.38 | 220,230 | $744K | 12.1% |
| 5 | $0.00 | 900,000 | $0 | 0.0% |
| Total | $2.42 avg | 2,544,794 |
| $6.1M |
| 100% |
| Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |
| CKPT | SELL | 2024-02-02 | $24K | — | Filing → |